25 XP 0   0   10  
0coffee
Main menu
3rd party ad coffee SUPPORTERis ad-free.

IDT Australia Ltd
Buy, Hold or Sell?

Let's analyze IDT Australia Ltd together

I guess you are interested in IDT Australia Ltd. Buy, hold or sell? I don't know! However, I do recommend doing research before doing anything. I will help you with that.

I'm going to help you getting a better view of IDT Australia Ltd. At the end you don't have to ask anyone for trading advice. You can make your own decision, with more confidence, the odds in your favor, backed by data.

Get notifications about IDT Australia Ltd

I send you an email if I find something interesting about IDT Australia Ltd.

1. Quick Overview

1.1. Quick analysis of IDT Australia Ltd (30 sec.)










1.2. What can you expect buying and holding a share of IDT Australia Ltd? (30 sec.)

How much money do you get?

How much money do you get?
A$0.00
When do you have the money?
1 year
How often do you get paid?
30.0%

What is your share worth?

Current worth
A$0.05
Expected worth in 1 year
A$0.05
How sure are you?
40.0%

+ What do you gain per year?

Total Gains per Share
A$-0.01
Return On Investment
-5.4%

For what price can you sell your share?

Current Price per Share
A$0.12
Expected price per share
A$0.12 - A$0.13
How sure are you?
50%
3rd party ad coffee SUPPORTERis ad-free.

2. Detailed Analysis

2.1. Valuation of IDT Australia Ltd (5 min.)




Live pricePrice per Share (EOD)
A$0.12
Intrinsic Value Per Share
A$-0.39 - A$-0.16
Total Value Per Share
A$-0.33 - A$-0.10

2.2. Growth of IDT Australia Ltd (5 min.)




Is IDT Australia Ltd growing?

Current yearPrevious yearGrowGrow %
How rich?$15.5m$16m-$464.2k-3.0%

How much money is IDT Australia Ltd making?

Current yearPrevious yearGrowGrow %
Making money-$3.5m-$5.6m$2m57.0%
Net Profit Margin-40.9%-122.5%--

How much money comes from the company's main activities?

2.3. Financial Health of IDT Australia Ltd (5 min.)




3rd party ad coffee SUPPORTERis ad-free.

3. Summary and Key Metrics

3.1. What can you expect buying and holding a share of IDT Australia Ltd?

Welcome investor! IDT Australia Ltd's management wants to use your money to grow the business. In return you get a share of IDT Australia Ltd.

First you should know what it really means to hold a share of IDT Australia Ltd. And how you can make/lose money.

Speculation

The Price per Share of IDT Australia Ltd is A$0.12. The market price reflects what other people think it is worth; not what it's really worth. Your job is to find out if the market price is fair, overpriced, or underpriced. I will help you with that.

If you buy blind, there is a 50% chance of making or losing money by selling the stock in the future. However, we can look at a few things to determine the odds in our favor:

  • The fundamentals: the financial health trends of IDT Australia Ltd.
  • The technials: based on market psychology, we can make a calculated estimate of what the price will do in the future. We can do this through technical analysis. We can calculate the probabilities and the expected value (millionaire math). That's called speculation.
  • The book value: what is the market price compared to it's book value.

Investing

If you really want to invest in IDT Australia Ltd, you will have to let go of the thought of selling in the future. If you have to sell the share for less than you bought it, it can still be a good investment. Focus on what it means to hold the stock forever:

  • You own a part of the company. The equity of this part can grow or shrink. The current Book Value per Share is A$0.05. Based on the TTM, the Book Value Change Per Share is A$0.00 per quarter. Based on the YOY, the Book Value Change Per Share is A$-0.01 per quarter.
  • You may receive quarterly/yearly dividend in the form of additional shares.
  • You may receive quarterly/yearly dividend in the form of cash. Based on the TTM the Dividend per Share is A$0.00 per quarter.
Based on historical numbers we can estimate the returns while holding a share of IDT Australia Ltd.

How much money are you going to get?

 MRQTTMYOY5Y10Y
 A$% of Price per ShareA$% of Price per ShareA$% of Price per ShareA$% of Price per ShareA$% of Price per Share
Usd Eps-0.01-7.0%-0.01-7.0%-0.01-10.9%0.00-3.8%-0.01-5.9%
Usd Book Value Change Per Share0.00-0.9%0.00-0.9%0.00-3.2%0.00-0.4%0.00-0.3%
Usd Dividend Per Share0.000.0%0.000.0%0.000.0%0.000.0%0.003.4%
Usd Total Gains Per Share0.00-0.9%0.00-0.9%0.00-3.2%0.00-0.4%0.003.1%
Usd Price Per Share0.07-0.07-0.04-0.10-0.11-
Price to Earnings Ratio-8.74--8.74--3.29--5.03--15.48-
Price-to-Total Gains Ratio-67.55--67.55--11.25--27.56--13.27-
Price to Book Ratio2.02-2.02-1.16-2.63-2.29-
Price-to-Total Gains Ratio-67.55--67.55--11.25--27.56--13.27-

When do you get the money?

Usd Investment
$.00
Usd Price Per Share0.079584
Number of shares12565
Gains per QuarterTrailing 12 Months5 Year
Usd Dividend Per Share0.000.00
Usd Book Value Change Per Share0.000.00
Usd Total Gains Per Share0.000.00
Gains per Quarter (12565 shares)-13.57-6.08
Gains per Year (12565 shares)-54.28-24.33
YearsReturn on Investment (TTM)Return on Investment (5Y)
 DividendBook Value gainTotal gainsDividendBook Value gainTotal gains
Broker costs---10---10
10-54-640-24-34
20-109-1180-49-58
30-163-1720-73-82
40-217-2260-97-106
50-271-2800-122-130
60-326-3340-146-154
70-380-3880-170-178
80-434-4420-195-202
90-489-4960-219-226
100-543-5500-243-250

How sure are you?

Based on the past periods, how sure are you to get value out of your investment.

Linear %
 Trailing 12 Months3Y5 Year10 YearALLTIME
  % % % % %
Earnings Per Share0.01.00.00.0%0.03.00.00.0%1.04.00.020.0%1.09.00.010.0%21.015.00.058.3%
Book Value Change Per Share0.01.00.00.0%0.03.00.00.0%1.04.00.020.0%4.06.00.040.0%23.013.00.063.9%
Dividend per Share0.00.01.00.0%0.00.03.00.0%0.00.05.00.0%3.00.07.030.0%25.00.011.069.4%
Total Gains per Share0.01.00.00.0%0.03.00.00.0%1.04.00.020.0%4.06.00.040.0%25.011.00.069.4%
3rd party ad coffee SUPPORTERis ad-free.

3.2. Key Performance Indicators

The key performance indicators of IDT Australia Ltd compared to the Most Recent Quarter (MRQ).

 End of day+/-Most Recent QuarterTrailing 12 Months+/-Year-Over-Year+/-5 Year+/-10 Year+/-
Book Value Change Per Share---0.002-0.0020%-0.006+255%-0.001-55%0.000-70%
Book Value Per Share--0.0550.0550%0.056-3%0.058-6%0.073-25%
Current Ratio--1.3421.3420%2.447-45%2.727-51%2.614-49%
Debt To Asset Ratio--0.2530.2530%0.147+72%0.178+42%0.169+50%
Debt To Equity Ratio--0.3380.3380%0.172+97%0.221+53%0.206+64%
Dividend Per Share----0%-0%-0%0.006-100%
Eps---0.013-0.0130%-0.020+57%-0.007-45%-0.011-16%
Free Cash Flow Per Share---0.024-0.0240%-0.020-18%-0.009-62%-0.008-67%
Free Cash Flow To Equity Per Share---0.008-0.0080%-0.011+35%-0.004-51%0.001-790%
Gross Profit Margin--2.9612.9610%1.676+77%2.119+40%1.796+65%
Intrinsic Value_10Y_max---0.156--------
Intrinsic Value_10Y_min---0.386--------
Intrinsic Value_1Y_max---0.010--------
Intrinsic Value_1Y_min---0.020--------
Intrinsic Value_3Y_max---0.034--------
Intrinsic Value_3Y_min---0.076--------
Intrinsic Value_5Y_max---0.063--------
Intrinsic Value_5Y_min---0.150--------
Market Cap51581038.080+8%47282618.24047282618.2400%27939728.960+69%67055349.504-29%68817701.638-31%
Net Profit Margin---0.409-0.4090%-1.225+199%-0.347-15%-0.576+41%
Operating Margin---0.450-0.4500%-1.410+213%-0.409-9%-0.463+3%
Operating Ratio--1.5181.5180%2.410-37%1.423+7%1.652-8%
Pb Ratio2.200+8%2.0172.0170%1.157+74%2.627-23%2.292-12%
Pe Ratio-9.529-9%-8.735-8.7350%-3.288-62%-5.033-42%-15.483+77%
Price Per Share0.120+8%0.1100.1100%0.065+69%0.156-29%0.160-31%
Price To Free Cash Flow Ratio-5.010-9%-4.592-4.5920%-3.317-28%-180.965+3841%-82.288+1692%
Price To Total Gains Ratio-73.687-9%-67.547-67.5470%-11.248-83%-27.559-59%-13.272-80%
Quick Ratio--0.6990.6990%1.830-62%2.217-68%2.036-66%
Return On Assets---0.173-0.1730%-0.300+74%-0.103-40%-0.154-11%
Return On Equity---0.231-0.2310%-0.352+52%-0.127-45%-0.187-19%
Total Gains Per Share---0.002-0.0020%-0.006+255%-0.001-55%0.006-129%
Usd Book Value--15546071.20015546071.2000%16010311.863-3%16595916.933-6%20830117.266-25%
Usd Book Value Change Per Share---0.001-0.0010%-0.004+255%0.000-55%0.000-70%
Usd Book Value Per Share--0.0360.0360%0.037-3%0.039-6%0.048-25%
Usd Dividend Per Share----0%-0%-0%0.004-100%
Usd Eps---0.008-0.0080%-0.013+57%-0.005-45%-0.007-16%
Usd Free Cash Flow---6828307.200-6828307.2000%-5586796.800-18%-2596560.640-62%-2265491.200-67%
Usd Free Cash Flow Per Share---0.016-0.0160%-0.013-18%-0.006-62%-0.005-67%
Usd Free Cash Flow To Equity Per Share---0.005-0.0050%-0.007+35%-0.003-51%0.001-790%
Usd Market Cap34208544.455+8%31357832.41731357832.4170%18529628.246+69%44471107.791-29%45639899.727-31%
Usd Price Per Share0.080+8%0.0730.0730%0.043+69%0.103-29%0.106-31%
Usd Profit---3589901.600-3589901.6000%-5635873.600+57%-1974611.680-45%-3947698.000+10%
Usd Revenue--8771483.2008771483.2000%4599292.000+91%8271032.480+6%8002171.200+10%
Usd Total Gains Per Share---0.001-0.0010%-0.004+255%0.000-55%0.004-129%
 EOD+5 -3MRQTTM+0 -0YOY+21 -135Y+5 -2910Y+8 -28

3.3 Fundamental Score

Let's check the fundamental score of IDT Australia Ltd based on Penke's default stock scanner.

Penke's Stock Scanner

  
  
IndicatorConditionValue
Price to Earnings Ratio (EOD)Between0-15-9.529
Price to Book Ratio (EOD)Between0-12.200
Net Profit Margin (MRQ)Greater than0-0.409
Operating Margin (MRQ)Greater than0-0.450
Quick Ratio (MRQ)Greater than10.699
Current Ratio (MRQ)Greater than11.342
Debt to Asset Ratio (MRQ)Less than10.253
Debt to Equity Ratio (MRQ)Less than10.338
Return on Equity (MRQ)Greater than0.15-0.231
Return on Assets (MRQ)Greater than0.05-0.173
Total3/10 (30.0%)

3.4 Technical Score

Let's check the technical score of IDT Australia Ltd based on Penke's default Symbol scanner.

Penke's Symbol Scanner

  
  
IndicatorConditionValue
RsiGreater than5045.270
Ma 20Greater thanMa 500.126
Ma 50Greater thanMa 1000.120
Ma 100Greater thanMa 2000.119
OpenGreater thanClose0.130
Total4/5 (80.0%)

4. In-depth Analysis

4.1 About IDT Australia Ltd

IDT Australia Limited engages in the research, development, manufacture, and sale of active pharmaceutical ingredients (API) and finished dose forms (FDF) products in Australia, Asia, Europe, and the Unites States. and internationally. It offers microbiological and analytical testing, clinical packaging, and pharmacy services. The company also provides medicinal cannabis and psychedelics; oral finished doses; and aseptic fill and finish solutions for liquid and lyophilised forms. In addition, it offers mRNA and ADCs. Further, the company provides contract manufacturing services. IDT Australia Limited was founded in 1975 and is headquartered in Boronia, Australia.

Fundamental data was last updated by Penke on 2024-10-17 20:45:05.

4.2 In-depth Summary

4.2.1. Financial Health Summary

Profitability Details
 Compared to previous yearCompared to industry
The company is making a huge loss.
Using its assets, the company is very inefficient in making profit.
Using its investors money, the company is very inefficient in making profit.
Operating Efficiency Details
 Compared to previous yearCompared to industry
The company is operating very inefficient.
The company is inefficient in keeping operating costs low.
Liquidity Details
 Compared to previous yearCompared to industry
The company is just able to pay all its short-term debts.
The company is just not able to pay all its short-term debts with the most liquid assets.
Solvency Details
 Compared to previous yearCompared to industry
The company is very able to pay all its debts by selling its assets.
The company is very able to pay all its debts with equity.

4.2.2. Valuation Summary

Valuation Details
 Compared to previous yearCompared to industry
Based on the equity, the company is underpriced.
Based on the earnings, the company is expensive.
Based on how much money comes from the company's main activities, the company is expensive.
3rd party ad coffee SUPPORTERis ad-free.

4.3 Financial Health

4.3.1. Profitability

4.3.1 Profitability
4.3.1.1. Net Profit Margin

Measures how much net profit IDT Australia Ltd earns for each $1 of revenue.

  • Above 10% is considered healthy but always compare IDT Australia Ltd to the Drug Manufacturers - Specialty & Generic industry mean.
  • A Net Profit Margin of -40.9% means that $-0.41 for each $1 in revenue is generated as profit.

Let's take a look of the Net Profit Margin trends of IDT Australia Ltd:

  • The MRQ is -40.9%. The company is making a huge loss. -2
  • The TTM is -40.9%. The company is making a huge loss. -2
Trends
Current periodCompared to+/- 
MRQ-40.9%TTM-40.9%0.0%
TTM-40.9%YOY-122.5%+81.6%
TTM-40.9%5Y-34.7%-6.2%
5Y-34.7%10Y-57.6%+22.9%
4.3.1.2. Return on Assets

Shows how efficient IDT Australia Ltd is using its assets to generate profit.

  • Above 5% is considered healthy but always compare IDT Australia Ltd to the Drug Manufacturers - Specialty & Generic industry mean.
  • -17.3% Return on Assets means that IDT Australia Ltd generated $-0.17 profit for each $1 in assets.

Let's take a look of the Return on Assets trends of IDT Australia Ltd:

  • The MRQ is -17.3%. Using its assets, the company is very inefficient in making profit. -2
  • The TTM is -17.3%. Using its assets, the company is very inefficient in making profit. -2
Trends
Current periodCompared to+/- 
MRQ-17.3%TTM-17.3%0.0%
TTM-17.3%YOY-30.0%+12.8%
TTM-17.3%5Y-10.3%-6.9%
5Y-10.3%10Y-15.4%+5.1%
4.3.1.3. Return on Equity

Shows how efficient IDT Australia Ltd is using its investors money to generate profit.

  • Above 15%-20% is considered healthy but always compare IDT Australia Ltd to the Drug Manufacturers - Specialty & Generic industry mean.
  • -23.1% Return on Equity means IDT Australia Ltd generated $-0.23 for each $1 the owners (shareholders) invested.

Let's take a look of the Return on Equity trends of IDT Australia Ltd:

  • The MRQ is -23.1%. Using its investors money, the company is very inefficient in making profit. -2
  • The TTM is -23.1%. Using its investors money, the company is very inefficient in making profit. -2
Trends
Current periodCompared to+/- 
MRQ-23.1%TTM-23.1%0.0%
TTM-23.1%YOY-35.2%+12.1%
TTM-23.1%5Y-12.7%-10.4%
5Y-12.7%10Y-18.7%+6.0%
3rd party ad coffee SUPPORTERis ad-free.

4.3.2. Operating Efficiency of IDT Australia Ltd.

4.3.2. Operating Efficiency
4.3.2.1. Operating Margin

Measures how efficient IDT Australia Ltd is operating .

  • Measures how much profit IDT Australia Ltd makes for each $1 of sales after paying variable costs (production costs, wages, etc) but before taxes.
  • Above 15% is considered healthy but always compare IDT Australia Ltd to the Drug Manufacturers - Specialty & Generic industry mean.
  • An Operating Margin of -45.0% means the company generated $-0.45  for each $1 in revenue (before taxes).

Let's take a look of the Operating Margin trends of IDT Australia Ltd:

  • The MRQ is -45.0%. The company is operating very inefficient. -2
  • The TTM is -45.0%. The company is operating very inefficient. -2
Trends
Current periodCompared to+/- 
MRQ-45.0%TTM-45.0%0.0%
TTM-45.0%YOY-141.0%+95.9%
TTM-45.0%5Y-40.9%-4.1%
5Y-40.9%10Y-46.3%+5.4%
4.3.2.2. Operating Ratio

Measures how efficient IDT Australia Ltd is keeping operating costs low.

  • Below 1 is considered healthy (always compare to Drug Manufacturers - Specialty & Generic industry mean).
  • An Operation Ratio of 1.52 means that the operating costs are $1.52 for each $1 in net sales.

Let's take a look of the Operating Ratio trends of IDT Australia Ltd:

  • The MRQ is 1.518. The company is inefficient in keeping operating costs low. -1
  • The TTM is 1.518. The company is inefficient in keeping operating costs low. -1
Trends
Current periodCompared to+/- 
MRQ1.518TTM1.5180.000
TTM1.518YOY2.410-0.892
TTM1.5185Y1.423+0.095
5Y1.42310Y1.652-0.229
3rd party ad coffee SUPPORTERis ad-free.

4.4.3. Liquidity of IDT Australia Ltd.

4.4.3. Liquidity
4.4.3.1. Current Ratio

Measures if IDT Australia Ltd is able to pay off Short-term Debt.

  • Above 1.5 is considered healthy (always compare to Drug Manufacturers - Specialty & Generic industry mean).
  • A Current Ratio of 1.34 means the company has $1.34 in assets for each $1 in short-term debts.

Let's take a look of the Current Ratio trends of IDT Australia Ltd:

  • The MRQ is 1.342. The company is just able to pay all its short-term debts.
  • The TTM is 1.342. The company is just able to pay all its short-term debts.
Trends
Current periodCompared to+/- 
MRQ1.342TTM1.3420.000
TTM1.342YOY2.447-1.105
TTM1.3425Y2.727-1.385
5Y2.72710Y2.614+0.113
4.4.3.2. Quick Ratio

Measures if IDT Australia Ltd is able to pay off Short-term Debt but only using the most liquid assets.

  • Above 1 is considered healthy but always compare IDT Australia Ltd to the Drug Manufacturers - Specialty & Generic industry mean.
  • A Quick Ratio of 0.70 means the company can pay off $0.70 for each $1 in debt (using most liquid assets).

Let's take a look of the Quick Ratio trends of IDT Australia Ltd:

  • The MRQ is 0.699. The company is just not able to pay all its short-term debts with the most liquid assets. -1
  • The TTM is 0.699. The company is just not able to pay all its short-term debts with the most liquid assets. -1
Trends
Current periodCompared to+/- 
MRQ0.699TTM0.6990.000
TTM0.699YOY1.830-1.131
TTM0.6995Y2.217-1.518
5Y2.21710Y2.036+0.180
3rd party ad coffee SUPPORTERis ad-free.

4.5.4. Solvency of IDT Australia Ltd.

4.5.4. Solvency
4.5.4.1. Debt to Asset Ratio

Measures how much % of IDT Australia Ltd assets are financed with debt.

  • Below 1 (100%) is considered healthy but always compare IDT Australia Ltd to Drug Manufacturers - Specialty & Generic industry mean.
  • A Debt to Asset Ratio of 0.25 means that IDT Australia Ltd assets are financed with 25.3% credit (debt) and the remaining percentage (100% - 25.3%) is financed by its owners/shareholders. 

Let's take a look of the Debt to Asset Ratio trends of IDT Australia Ltd:

  • The MRQ is 0.253. The company is very able to pay all its debts by selling its assets. +2
  • The TTM is 0.253. The company is very able to pay all its debts by selling its assets. +2
Trends
Current periodCompared to+/- 
MRQ0.253TTM0.2530.000
TTM0.253YOY0.147+0.106
TTM0.2535Y0.178+0.075
5Y0.17810Y0.169+0.009
4.5.4.2. Debt to Equity Ratio

Measures if IDT Australia Ltd is able to pay off its debts by using shareholders equity.

  • Below 2 is considered healthy but always compare IDT Australia Ltd to the Drug Manufacturers - Specialty & Generic industry mean.
  • A Debt to Equity ratio of 33.8% means that company has $0.34 debt for each $1 in shareholders equity.

Let's take a look of the Debt to Equity Ratio trends of IDT Australia Ltd:

  • The MRQ is 0.338. The company is very able to pay all its debts with equity. +2
  • The TTM is 0.338. The company is very able to pay all its debts with equity. +2
Trends
Current periodCompared to+/- 
MRQ0.338TTM0.3380.000
TTM0.338YOY0.172+0.166
TTM0.3385Y0.221+0.118
5Y0.22110Y0.206+0.015
3rd party ad coffee SUPPORTERis ad-free.

4.6. Market Valuation

4.6.1. Earnings Per Share
4.6.2.1. Price to Earnings Ratio

Measures how much money you pay for each share for every $1 in earnings IDT Australia Ltd generates.

  • Above 15 is considered overpriced but always compare IDT Australia Ltd to the Drug Manufacturers - Specialty & Generic industry mean.
  • A PE ratio of -8.74 means the investor is paying $-8.74 for every $1 in earnings.

Let's take a look of the Price to Earnings Ratio trends of IDT Australia Ltd:

  • The EOD is -9.529. Based on the earnings, the company is expensive. -2
  • The MRQ is -8.735. Based on the earnings, the company is expensive. -2
  • The TTM is -8.735. Based on the earnings, the company is expensive. -2
Trends
Current periodCompared to+/- 
EOD-9.529MRQ-8.735-0.794
MRQ-8.735TTM-8.7350.000
TTM-8.735YOY-3.288-5.447
TTM-8.7355Y-5.033-3.702
5Y-5.03310Y-15.483+10.450
4.6.2.2. Price To Free Cash Flow Ratio

Let's take a look of the Price To Free Cash Flow Ratio trends of IDT Australia Ltd:

  • The EOD is -5.010. Based on how much money comes from the company's main activities, the company is expensive. -2
  • The MRQ is -4.592. Based on how much money comes from the company's main activities, the company is expensive. -2
  • The TTM is -4.592. Based on how much money comes from the company's main activities, the company is expensive. -2
Trends
Current periodCompared to+/- 
EOD-5.010MRQ-4.592-0.417
MRQ-4.592TTM-4.5920.000
TTM-4.592YOY-3.317-1.276
TTM-4.5925Y-180.965+176.373
5Y-180.96510Y-82.288-98.677
3rd party ad coffee SUPPORTERis ad-free.
4.6.2. Book Value per Share
4.6.2.1. Price to Book Ratio

Measures if the stock price of IDT Australia Ltd is to cheap or to expensive compared to its book value.

Let's take a look of the Price to Book Ratio trends of IDT Australia Ltd:

  • The EOD is 2.200. Based on the equity, the company is underpriced. +1
  • The MRQ is 2.017. Based on the equity, the company is underpriced. +1
  • The TTM is 2.017. Based on the equity, the company is underpriced. +1
Trends
Current periodCompared to+/- 
EOD2.200MRQ2.017+0.183
MRQ2.017TTM2.0170.000
TTM2.017YOY1.157+0.860
TTM2.0175Y2.627-0.610
5Y2.62710Y2.292+0.335
4.6.2. Total Gains per Share

4.7 Holders & Insider Transactions

Let's take a look at which institutions, funds and insiders are holding shares of IDT Australia Ltd.

3rd party ad coffee SUPPORTERis ad-free.

5. Financial Statements




5.1. Reversals in quarterly reports

I have detected a reversal (positive to negative, negative to positive) in the following values of the quarterly reports.

 2020-06-302021-06-302022-06-302023-06-302024-06-30
Net Debt  -6,855693-6,162-2,171-8,3334,640-3,6937,6573,964



5.2. Latest Balance Sheet

Balance Sheet of 2024-06-30. All numbers in thousands.

Summary
Total Assets31,371
Total Liabilities7,930
Total Stockholder Equity23,441
 As reported
Total Liabilities 7,930
Total Stockholder Equity+ 23,441
Total Assets = 31,371

Assets

Total Assets31,371
Total Current Assets10,407
Long-term Assets20,964
Total Current Assets
Cash And Cash Equivalents 504
Short-term Investments 400
Net Receivables 4,119
Inventory 1,681
Other Current Assets 2,449
Total Current Assets  (as reported)10,407
Total Current Assets  (calculated)9,153
+/- 1,254
Long-term Assets
Property Plant Equipment 20,964
Long-term Assets  (as reported)20,964
Long-term Assets  (calculated)20,964
+/-0

Liabilities & Shareholders' Equity

Total Current Liabilities7,757
Long-term Liabilities173
Total Stockholder Equity23,441
Total Current Liabilities
Short-term Debt 4,468
Accounts payable 661
Other Current Liabilities 2,296
Total Current Liabilities  (as reported)7,757
Total Current Liabilities  (calculated)7,425
+/- 332
Long-term Liabilities
Long-term Liabilities  (as reported)173
Long-term Liabilities  (calculated)0
+/- 173
Total Stockholder Equity
Common Stock57,700
Retained Earnings -46,974
Accumulated Other Comprehensive Income 12,715
Total Stockholder Equity (as reported)23,441
Total Stockholder Equity (calculated)23,441
+/-0
Other
Cash and Short Term Investments 904
Common Stock Shares Outstanding 348,222
Current Deferred Revenue332
Liabilities and Stockholders Equity 31,371
Net Debt 3,964
Net Working Capital 2,650
Short Long Term Debt Total 4,468



5.3. Balance Sheets Structured

All numbers in thousands.

 Trend2024-06-302023-06-302022-06-302021-06-302020-06-302019-06-302018-06-302017-06-302016-06-302015-06-302014-06-302013-06-302012-06-302011-06-302010-06-302009-06-302008-06-302007-06-302006-06-302005-06-302004-06-302003-06-302002-06-302001-06-302000-06-301999-06-301998-06-301997-06-301996-06-301995-06-301994-06-301993-06-301992-06-301991-06-301990-06-301989-06-30
> Total Assets 
4,605
4,387
3,221
3,394
3,546
6,035
7,767
10,244
10,944
12,412
14,559
18,464
28,225
32,814
34,243
36,560
37,280
35,376
36,916
42,341
39,460
33,091
32,451
31,775
30,706
28,295
43,200
52,911
58,115
38,912
31,201
28,587
34,129
30,080
28,289
31,371
31,37128,28930,08034,12928,58731,20138,91258,11552,91143,20028,29530,70631,77532,45133,09139,46042,34136,91635,37637,28036,56034,24332,81428,22518,46414,55912,41210,94410,2447,7676,0353,5463,3943,2214,3874,605
   > Total Current Assets 
1,270
1,265
1,000
1,503
1,683
3,598
2,219
2,299
2,110
3,206
4,262
6,321
12,351
12,316
11,614
13,475
13,405
11,774
12,696
16,045
11,418
5,961
5,101
4,775
5,188
5,147
4,837
9,570
19,405
18,952
13,419
12,813
17,266
13,865
9,743
10,407
10,4079,74313,86517,26612,81313,41918,95219,4059,5704,8375,1475,1884,7755,1015,96111,41816,04512,69611,77413,40513,47511,61412,31612,3516,3214,2623,2062,1102,2992,2193,5981,6831,5031,0001,2651,270
       Cash And Cash Equivalents 
-127
-276
1
319
387
2,285
1
1
1
69
680
1,817
4,266
2,052
3,427
4,053
2,236
367
1,856
2,028
1,834
1,131
1,232
13
578
2,415
129
21
8,417
14,027
9,497
6,860
6,928
9,214
4,433
504
5044,4339,2146,9286,8609,49714,0278,417211292,415578131,2321,1311,8342,0281,8563672,2364,0533,4272,0524,2661,817680691112,2853873191-276-127
       Short-term Investments 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
400
40000000000000000000000000000000000000
       Net Receivables 
1,055
1,115
753
1,020
1,063
1,086
1,631
1,836
1,461
2,124
2,629
3,774
6,095
8,359
6,155
6,692
8,738
9,792
9,945
12,852
8,341
3,715
2,319
2,366
3,251
1,493
3,490
5,849
1,644
2,490
2,407
4,628
8,653
2,306
2,853
4,119
4,1192,8532,3068,6534,6282,4072,4901,6445,8493,4901,4933,2512,3662,3193,7158,34112,8529,9459,7928,7386,6926,1558,3596,0953,7742,6292,1241,4611,8361,6311,0861,0631,0207531,1151,055
       Inventory 
215
150
246
113
187
168
479
274
318
459
601
336
1,612
1,375
1,291
1,883
1,581
1,147
895
848
775
697
1,125
1,242
675
647
347
1,196
333
1,055
489
444
453
1,102
1,372
1,681
1,6811,3721,1024534444891,0553331,1963476476751,2421,1256977758488951,1471,5811,8831,2911,3751,612336601459318274479168187113246150215
       Other Current Assets 
127
276
0
51
46
59
108
187
330
554
352
394
378
165
741
433
430
826
337
317
468
418
425
714
271
592
871
2,504
9,011
1,380
1,026
881
1,232
1,243
1,085
2,449
2,4491,0851,2431,2328811,0261,3809,0112,5048715922717144254184683173378264304337411653783943525543301871085946510276127
   > Long-term Assets 
3,335
3,122
2,221
1,891
1,863
2,437
5,548
7,946
8,834
9,206
10,297
12,142
15,875
20,498
22,629
23,085
23,875
23,602
24,220
26,296
28,042
27,130
27,350
27,000
25,518
21,210
35,627
37,908
31,849
18,709
16,676
15,774
16,863
16,215
18,546
20,964
20,96418,54616,21516,86315,77416,67618,70931,84937,90835,62721,21025,51827,00027,35027,13028,04226,29624,22023,60223,87523,08522,62920,49815,87512,14210,2979,2068,8347,9465,5482,4371,8631,8912,2213,1223,335
       Property Plant Equipment 
1,858
1,828
1,569
1,349
1,457
2,135
5,348
7,848
7,714
7,692
8,747
10,492
13,757
18,173
20,526
21,298
22,081
23,602
22,324
26,296
28,042
27,130
27,350
26,070
25,518
21,210
19,923
22,204
19,525
18,709
16,676
15,526
16,743
16,215
18,546
20,964
20,96418,54616,21516,74315,52616,67618,70919,52522,20419,92321,21025,51826,07027,35027,13028,04226,29622,32423,60222,08121,29820,52618,17313,75710,4928,7477,6927,7147,8485,3482,1351,4571,3491,5691,8281,858
       Goodwill 
126
111
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0000000000000000000000000000000000111126
       Intangible Assets 
1,219
1,065
613
510
406
302
200
98
0
0
0
0
0
0
0
0
0
0
1,896
0
0
0
0
0
0
0
15,704
15,704
12,324
1,251
1,106
248
120
0
0
0
0001202481,1061,25112,32415,70415,70400000001,8960000000000982003024065106131,0651,219
       Long-term Assets Other 
52
44
39
32
0
0
0
0
1,120
1,514
1,550
1,650
2,118
1,960
2,103
1,787
1,794
0
-1,896
0
0
0
0
0
-2,924
-21,210
-35,627
-37,908
-31,849
-1,251
-1,106
0
0
-16,215
-18,546
0
0-18,546-16,21500-1,106-1,251-31,849-37,908-35,627-21,210-2,92400000-1,89601,7941,7872,1031,9602,1181,6501,5501,5141,120000032394452
> Total Liabilities 
2,016
1,787
1,461
1,037
1,120
1,076
2,782
5,013
5,229
6,102
7,096
7,980
7,754
9,554
7,831
8,670
8,132
6,684
6,526
9,480
5,248
2,949
2,479
3,640
4,677
2,744
3,995
9,535
9,197
6,456
6,191
5,289
6,514
3,455
4,148
7,930
7,9304,1483,4556,5145,2896,1916,4569,1979,5353,9952,7444,6773,6402,4792,9495,2489,4806,5266,6848,1328,6707,8319,5547,7547,9807,0966,1025,2295,0132,7821,0761,1201,0371,4611,7872,016
   > Total Current Liabilities 
1,320
1,130
925
648
905
757
2,049
2,435
2,344
2,678
2,971
4,337
4,291
6,675
3,402
4,169
3,994
2,984
3,882
7,640
2,458
1,140
1,241
3,386
4,577
2,581
3,841
7,301
5,886
4,825
4,960
4,952
6,069
3,141
3,982
7,757
7,7573,9823,1416,0694,9524,9604,8255,8867,3013,8412,5814,5773,3861,2411,1402,4587,6403,8822,9843,9944,1693,4026,6754,2914,3372,9712,6782,3442,4352,0497579056489251,1301,320
       Short-term Debt 
592
684
517
252
133
46
344
423
885
615
577
460
416
1,029
147
586
596
582
576
334
12
74
55
800
1,931
39
436
2,575
122
129
4
5
766
881
740
4,468
4,468740881766541291222,575436391,9318005574123345765825965861471,02941646057761588542334446133252517684592
       Short Long Term Debt 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
88
454
2,554
664
542
0
0
766
881
740
0
0740881766005426642,554454880000000000000000000000000
       Accounts payable 
102
70
97
80
122
118
1,179
1,261
1,101
1,645
969
1,589
1,855
3,020
1,939
2,561
1,945
2,149
2,038
4,776
1,804
1,066
1,186
1,001
1,662
574
847
1,497
683
576
433
397
2,582
550
346
661
6613465502,5823974335766831,4978475741,6621,0011,1861,0661,8044,7762,0382,1491,9452,5611,9393,0201,8551,5899691,6451,1011,2611,179118122809770102
       Other Current Liabilities 
1,218
1,060
828
568
783
639
870
1,174
1,357
1,425
2,135
1,229
3,361
5,474
1,752
1,539
2,284
1,604
2,682
6,118
1,491
369
652
1,585
1,560
2,007
2,994
2,575
4,376
3,876
4,372
4,511
2,467
1,193
2,067
2,296
2,2962,0671,1932,4674,5114,3723,8764,3762,5752,9942,0071,5601,5856523691,4916,1182,6821,6042,2841,5391,7525,4743,3611,2292,1351,4251,3571,1748706397835688281,0601,218
   > Long-term Liabilities 
696
657
536
389
215
319
733
2,578
2,885
3,424
4,125
3,643
3,463
2,880
4,429
4,501
4,138
3,700
2,644
1,840
2,790
1,809
1,238
254
100
225
154
2,234
3,311
1,631
1,231
337
445
314
166
173
1731663144453371,2311,6313,3112,2341542251002541,2381,8092,7901,8402,6443,7004,1384,5014,4292,8803,4633,6434,1253,4242,8852,578733319215389536657696
       Long term Debt Total 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
18
17
542
413
5
0
0
0
0
0
000005413542171800000000000000000000000000
       Other Liabilities 
0
0
0
0
0
0
0
0
0
0
0
352
419
576
730
735
755
895
891
944
1,148
1,021
1,028
176
82
176
136
2,217
2,769
1,218
1,226
337
445
314
166
0
01663144453371,2261,2182,7692,217136176821761,0281,0211,14894489189575573573057641935200000000000
       Deferred Long Term Liability 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
1,938
2,736
5,433
6,861
1,251
1,106
248
120
0
0
0
0001202481,1061,2516,8615,4332,7361,9380000000000000000000000000
> Total Stockholder Equity
2,589
2,600
1,760
2,357
2,426
4,959
4,985
5,232
5,715
6,311
7,463
10,483
20,471
23,260
26,412
27,890
29,148
28,692
30,390
32,861
34,212
30,142
29,972
28,135
26,029
25,551
39,205
43,376
48,918
32,456
25,010
23,298
27,615
26,625
24,141
23,441
23,44124,14126,62527,61523,29825,01032,45648,91843,37639,20525,55126,02928,13529,97230,14234,21232,86130,39028,69229,14827,89026,41223,26020,47110,4837,4636,3115,7155,2324,9854,9592,4262,3571,7602,6002,589
   Common Stock
2,100
2,107
2,107
2,607
2,607
2,957
2,962
2,962
2,962
2,962
5,344
6,685
14,681
15,389
15,387
15,386
15,385
15,384
15,383
15,382
15,381
15,379
15,377
15,377
17,031
22,877
39,287
46,961
52,833
52,833
51,189
51,189
51,189
51,189
54,929
57,700
57,70054,92951,18951,18951,18951,18952,83352,83346,96139,28722,87717,03115,37715,37715,37915,38115,38215,38315,38415,38515,38615,38715,38914,6816,6855,3442,9622,9622,9622,9622,9572,6072,6072,1072,1072,100
   Retained Earnings 
109
112
-728
-631
-530
-433
-415
-113
371
966
2,119
3,799
5,790
7,871
11,025
12,504
13,763
12,085
13,687
16,069
17,321
13,162
12,926
11,089
5,735
-891
-3,883
-7,889
-8,662
-25,641
-31,724
-33,643
-31,540
-33,063
-41,561
-46,974
-46,974-41,561-33,063-31,540-33,643-31,724-25,641-8,662-7,889-3,883-8915,73511,08912,92613,16217,32116,06913,68712,08513,76312,50411,0257,8715,7903,7992,119966371-113-415-433-530-631-728112109
   Capital Surplus 000000000000000000000000000000000000
   Treasury Stock000000000000000000000000000000000000
   Other Stockholders Equity 
380
381
381
381
2,008
4,321
4,451
4,672
0
0
3,609
5,148
6,239
6,726
8,402
0
0
0
0
0
0
0
0
0
0
3,565
3,801
4,304
4,747
0
5,545
1
0
-18,126
-13,368
0
0-13,368-18,126015,54504,7474,3043,8013,56500000000008,4026,7266,2395,1483,609004,6724,4514,3212,008381381381380



5.4. Balance Sheets

All numbers in thousands.